相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发,品质稳、品类全,实验不再等!Takara 秋促来袭,提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ¥1200阿拉丁 22万+ 科研级产品现货速发,品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 供应商:
BD Pharmingen
- 靶点:
CD206
- 级别:
RUO
- 克隆性:
单克隆
- 抗原来源:
Human
- 抗体英文名:
CD206 Antibody
- 抗体名:
CD206
- 标记物:
PE-Cy5
- 宿主:
Mouse
- 适应物种:
Human
- 免疫原:
Human Placental Macrophage Mannose Receptor
- 亚型:
Mouse IgG1, κ
- 形态:
液体
- 应用范围:
Flow Cytometry (FCM)
- 保存条件:
2-8℃避光保存
- 规格:
100 Tests
产品概述
Hu CD206 PE-Cy5 19.2 100Tst 为 BD Pharmingen 品牌流式抗体,货号 551136,靶向 CD206,荧光标记 PE-Cy5,克隆 19.2 (RUO),规格 100 Tests。适用于 Flow cytometry (Routinely Tested) 检测,仅供科研使用(RUO)。
靶点与抗体说明
The 19.2 monoclonal antibody specifically binds to CD206 which is also known as the macrophage mannose receptor (MMR) or C-type lectin domain family 13 member D (CLEC13D). CD206 is a type I transmembrane glycoprotein of approximately 162 kDa which binds to glycoconjugates containing mannose, fucose, or N-acetylglucosamine. These carbohydrates are present on the surface of many microorganisms and enable the macrophage to bind to microorganisms through the MMR and internalize them during the process of phagocytosis. CD206 is expressed on human macrophages, endothelial cells, and cultured dendritic cells. It is not detected on resting monocytes. Mannose receptor expression is upregulated on peripheral blood mononuclear cells following 3 day incubation with GM-CSF. This antibody is routinely by flow cytometric analysis. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.
核心参数
| 货号 | 551136 |
| 品牌 | BD Pharmingen |
| 克隆号 | 克隆 19.2 (RUO) |
| 宿主 | Mouse |
| 同种型 | Mouse IgG1, κ |
| 荧光标记 | PE-Cy5 |
| 抗原 / 靶点 | CD206 |
| 反应种属 | Human |
| 验证应用 | Flow cytometry (Routinely Tested) |
| 推荐用量 | 20 µl |
| 免疫原 | Human Placental Macrophage Mannose Receptor |
| 规格 | 100 Tests |
| 存储缓冲液 | Aqueous buffered solution containing BSA and ≤0.09% sodium azide. |
荧光染料信息
PE-Cy5 PE-Cy5 dye is a part of the BD PE family of dyes. This tandem fluorochrome is comprised of a R-Phycoerythrin (PE) donor that has excitation maxima (Ex Max) of 496 nm and 566 nm and an acceptor dye, Cy™5, with an emission maximum (Em Max) at 670-nm. PE designed to be excited by the Blue (488-nm), Green (532-nm) and yellow-green (561-nm) lasers and detected using an optical filter centered near 670-nm (e.g., a 670/20-nm bandpass filter). The donor dye can be excited by the Blue (488-nm), Green (532-nm) and yellow-green (561-nm) lasers and the acceptor dye can be excited by the Red (627-640-nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye. 格式:PE-Cy5最多激发源:496 nm, 566 nm最多发射源:670 nm
保存与运输
建议 2-8℃ 避光保存,请勿冷冻,避免反复冻融。 存储缓冲液:Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
参考文献
Mason D. David Mason .. et al., ed. Leucocyte typing VII : white cell differentiation antigens : proceedings of the Seventh International Workshop and Conference held in Harrogate, United Kingdom. Oxford: Oxford University Press; 2002. Pontow SE, Kery V, Stahl PD. Mannose receptor. Int Rev Cytol. 1992; 137(B):221-244. (Clone-specific).
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验MACSQuant Tyto 细胞分选仪助力开发 COVID-19 新疗法
它来从 HIV 阳性患者材料中分选 CD4+T 细胞亚群。然而面对最近的 COVID-19 危机,我们将研究方向转向 SARS-CoV-2,目的是开发一种基于抗体的新治疗方法。 我们计划的工作流程是从 COVID-19 康复患者身上获取血浆,与病毒一起孵育,并测量中和水平。如果我们发现很好的中和抗体,我们也会测试他们对 2002 年的非典型肺炎病毒中和疗效。下一步,我们将尝试从那些能同时感染两种病毒的病人身上分离出 B 细胞。 通过这种方式,我们希望获得可以用于治疗的抗体。我们也用它与荧光团结合的刺突蛋白
Western Blotting with Horseradish Pe
of proteins from 10% or 13% gels to PVDF membranes semi-dry transfer can also be used. Transfer proteins to PVDF membrane at 1.2 mAmp/cm2 for 1 hour and 45 minutes in transfer buffer (25mM Tris, 190mM glycine, 20% MeOH). Optional If blots are not to be used
三句话读懂一篇 CNS!首次提取超 100 万年的 DNA;轻轻一喷,瞬时改变作物性状...
春节假期结束,开工号角持续吹响。 本周学术君继续为 大家带来 CNS 最新科研进展,助你尽快进入工作状态,成为合格的科研打工人! 1. Cell 报道新型免疫检查点 CD161,恶性脑肿瘤不再无药可医! 弥漫性神经胶质瘤是最常见的人类原发性脑瘤,在目前的医疗条件下无法彻底治愈。T 细胞是癌症免疫疗法的关键靶标,然而,学界对其基因表达程序并不了解。 2021 年 2 月 15 日,哈佛医学院 Kai W. Wucherpfennig 教授团队在 Cell 杂志上发表研究论文 Inhibitory
技术资料暂无技术资料 索取技术资料










